The Los Angeles Dodgers have placed pitcher Ted Lilly on the 15-day disabled list with inflammation of the left shoulder, the team said Monday. Lilly -- who missed the first eight games of the season for LA because of a stiff neck -- went on to post a 5-0 record in his first seven starts. In his most recent start on May 23, Lilly gave up eight runs on nine hits in 3 1/3 innings against the Arizona Diamondbacks, a performance that raised his ERA to 3.14. No MRI was taken and Lilly has been taking anti-inflammatory medication following a cortisone shot, mlb.com reported. The left-hander said he hopes he'll be able to throw again by the end of the week. "If that's the case, we're feeling it's short-term," said manager Don Mattingly. "He's had stuff before, and it sounds like something he caught early. In the past he would have thrown another game with it." The Dodgers recalled pitcher Michael Antonini from Triple-A Albuquerque to take Lilly's spot on the roster Monday but will replace Antononi with Nathan Eovaldi, who will be called up from Double-A Chattanooga to start Tuesday in place of Lilly against the Milwaukee Brewers.
GMT 18:30 2017 Tuesday ,26 December
FIFA trial: New York jury acquits former Peru soccer bossGMT 13:18 2017 Tuesday ,26 December
Early drama as Sydney to Hobart fleet race to break recordGMT 20:25 2017 Monday ,25 December
Klopp urges Liverpool to focus on Euro ambitionsGMT 18:35 2017 Monday ,25 December
Mutko suspends Russian football role to fight Olympic lifetime banGMT 10:11 2017 Monday ,25 December
Federer, Nadal shine as rivals hobble into 2018GMT 19:22 2017 Sunday ,24 December
Southampton's Austin charged with violent conductGMT 18:02 2017 Sunday ,24 December
'Tongan Bear' Uhila extends Clermont contractGMT 17:07 2017 Sunday ,24 December
Serena Williams to make competitive return in Abu Dhabi next week
Maintained and developed by Arabs Today Group SAL.
All rights reserved to Arab Today Media Group 2025 ©
Maintained and developed by Arabs Today Group SAL.
All rights reserved to Arab Today Media Group 2025 ©
Send your comments
Your comment as a visitor